Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5189803, 9 pages
https://doi.org/10.1155/2017/5189803
Review Article

Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?

Huzhou Central Hospital, No. 198 Hongqi Road, Huzhou, Zhejiang 313000, China

Correspondence should be addressed to Pan Yuefen; moc.361@352366nefeuynap

Received 11 January 2017; Accepted 14 February 2017; Published 16 March 2017

Academic Editor: Hong C. Jin

Copyright © 2017 Han Shuwen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Gibson, “Cancer: directions for the drivers,” Nature, vol. 512, no. 1, pp. 31–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Lee and L. R. Ferguson, “MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer,” World Journal of Gastroenterology, vol. 22, no. 33, pp. 7389–7401, 2016. View at Publisher · View at Google Scholar
  3. X. Xie, B. Tang, Y.-F. Xiao et al., “Long non-coding RNAs in colorectal cancer,” Oncotarget, vol. 7, no. 5, pp. 5226–5239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Alnabulsi and G. I. Murray, “Integrative analysis of the colorectal cancer proteome: potential clinical impact,” Expert Review of Proteomics, vol. 13, no. 10, pp. 917–927, 2016. View at Publisher · View at Google Scholar
  5. M. Yamamoto and S. Matsumoto, “Gut microbiota and colorectal cancer,” Genes and Environment, vol. 38, no. 1, article 11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Silva Ramos, N. G. Larsson, and A. Mourier, “Bioenergetic roles of mitochondrial fusion,” Biochimica et Biophysica Acta, vol. 1857, no. 8, pp. 1277–1283, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Hosp, I. Lassowskat, V. Santoro et al., “Lysine acetylation in mitochondria: from inventory to function,” Mitochondrion, vol. 33, pp. 58–71, 2017. View at Publisher · View at Google Scholar
  8. S. Shiratsuki, T. Hara, Y. Munakata, K. Shirasuna, T. Kuwayama, and H. Iwata, “Low oxygen level increases proliferation and metabolic changes in bovine granulosa cells,” Molecular and Cellular Endocrinology, vol. 437, pp. 75–85, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. X. K. Xing, M. H. Li, Z. W. Guo, and C. S. Xu, “Expression profiles of genes associated with mitochondria-mediated apoptosis and their roles in liver regeneration,” Genetics and Molecular Research, vol. 15, no. 3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Latorre-Pellicer, R. Moreno-Loshuertos, A. V. Lechuga-Vieco et al., “Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing,” Nature, vol. 535, no. 7613, pp. 561–565, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kubota, Y. B. Shui, M. Liu et al., “Mitochondrial oxygen metabolism in primary human lens epithelial cells: association with age, diabetes and glaucoma,” Free Radical Biology and Medicine, vol. 97, pp. 513–519, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Ridler, “Obesity: inheritance via mitochondria,” Nature Reviews Endocrinology, vol. 12, no. 9, article 497, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Guzmán-Fulgencio, J. L. Jiménez, M. García-Álvarez et al., “Mitochondrial haplogroups are associated with clinical pattern of AIDS progression in HIV-infected patients,” Journal of Acquired Immune Deficiency Syndromes, vol. 63, no. 2, pp. 178–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Andrews, I. Kubacka, P. F. Chinnery, R. N. Lightowlers, D. M. Turnbull, and N. Howell, “Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA,” Nature Genetics, vol. 23, no. 2, p. 147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. P. F. Chinnery and G. Hudson, “Mitochondrial genetics,” British Medical Bulletin, vol. 106, no. 1, pp. 135–159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Korzeniewski, M. Malgat, T. Letellier, and J.-P. Mazat, “Effect of ‘binary mitochondrial heteroplasmy’ on respiration and ATP synthesis: Implications for mitochondrial diseases,” Biochemical Journal, vol. 357, no. 3, pp. 835–842, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Rossignol, M. Malgat, J.-P. Mazat, and T. Letellier, “Threshold effect and tissue specificity. Implication for mitochondrial cytopathies,” Journal of Biological Chemistry, vol. 274, no. 47, pp. 33426–33432, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Wallace, “Mitochondrial diseases in man and mouse,” Science, vol. 283, no. 5407, pp. 1482–1488, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Wachsmuth, A. Hübner, M. Li, B. Madea, and M. Stoneking, “Age-related and heteroplasmy-related variation in human mtDNA copy number,” PLoS Genetics, vol. 12, no. 3, Article ID e1005939, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. F. H. M. van Osch, A. M. Voets, L. J. Schouten et al., “Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival,” Carcinogenesis, vol. 36, no. 12, pp. 1502–1510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Wang, V. W. S. Liu, W. C. Xue, A. N. Y. Cheung, and H. Y. S. Ngan, “Association of decreased mitochondrial DNA content with ovarian cancer progression,” British Journal of Cancer, vol. 95, no. 8, pp. 1087–1091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, S. He, X. Zhu, W. Qiao, and J. Zhang, “High copy number of mitochondrial DNA predicts poor prognosis in patients with advanced stage colon cancer,” The International Journal of Biological Markers, vol. 31, no. 4, pp. e382–e388, 2016. View at Publisher · View at Google Scholar
  23. A. M. S. Haja Mohideen, E. Dicks, P. Parfrey, R. Green, and S. Savas, “Mitochondrial DNA polymorphisms, its copy number change and outcome in colorectal cancer,” BMC Research Notes, vol. 8, article 272, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Wen, J. Gao, L. Zhang, H. Zhou, D. Fang, and S. Feng, “p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer,” Oncotarget, vol. 7, no. 46, pp. 75981–75995, 2016. View at Publisher · View at Google Scholar
  25. B. Thyagarajan, W. Guan, V. Fedirko et al., “No association between mitochondrial DNA copy number and colorectal adenomas,” Molecular Carcinogenesis, vol. 55, no. 8, pp. 1290–1296, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Thyagarajan, R. Wang, H. Barcelo, W.-P. Koh, and J.-M. Yuan, “Mitochondrial copy number is associated with colorectal cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 21, no. 9, pp. 1574–1581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Qu, Y. Chen, X. Wang et al., “Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer,” Carcinogenesis, vol. 36, no. 5, pp. 543–552, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Huang, Y.-T. Gao, X.-O. Shu et al., “Association of leukocyte mitochondrial DNA copy number with colorectal cancer risk: results from the Shanghai Women's Health Study,” Cancer Epidemiology Biomarkers and Prevention, vol. 23, no. 11, pp. 2357–2365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Sultana, D. W. Seo, M. S. Bhuiyan et al., “Genetic diversity and phylogenetic analysis of South-East Asian duck populations based on the mtDNA D-loop sequences,” Asian-Australasian Journal of Animal Sciences, vol. 29, no. 12, pp. 1688–1695, 2016. View at Google Scholar
  30. J. Zhang, Z. Guo, Y. Bai et al., “Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma,” Biomedical Reports, vol. 1, pp. 563–566, 2013. View at Google Scholar
  31. J.-W. Taanman, “The mitochondrial genome: structure, transcription, translation and replication,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1410, no. 2, pp. 103–123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Feng, L. Xiong, Z. Ji, W. Cheng, and H. Yang, “Correlation between increased ND2 expression and demethylated displacement loop of mtDNA in colorectal cancer,” Molecular Medicine Reports, vol. 6, no. 1, pp. 125–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Gao, S. Wen, H. Zhou, and S. Feng, “De-methylation of displacement loop of mitochondrial DNA is associated with increased mitochondrial copy number and nicotinamide adenine dinucleotide subunit 2 expression in colorectal cancer,” Molecular Medicine Reports, vol. 12, no. 5, pp. 7033–7038, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Govatati, B. Saradamma, S. Malempati et al., “Association of mitochondrial displacement loop polymorphisms with risk of colorectal cancer in south Indian population,” Mitochondrial DNA Part A: DNA Mapping, Sequencing, and Analysis, 2016. View at Publisher · View at Google Scholar
  35. Y. Bai, Z. Guo, J. Xu et al., “Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome,” Mitochondrial DNA, vol. 26, no. 2, pp. 224–226, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Legras, A. Lièvre, C. Bonaiti-Pellié et al., “Mitochondrial D310 mutations in colorectal adenomas: an early but not causative genetic event during colorectal carcinogenesis,” International Journal of Cancer, vol. 122, no. 10, pp. 2242–2248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Kassem, N. El-Guendy, M. Tantawy, H. Abdelhady, A. El-Ghor, and A. H. Abdel Wahab, “Mutational hotspots in the mitochondrial D-loop region of cancerous and precancerous colorectal lesions in egyptian patients,” DNA and Cell Biology, vol. 30, no. 11, pp. 899–906, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Akouchekian, M. Houshmand, S. Hemati, M. Ansaripour, and M. Shafa, “High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer,” Diseases of the Colon and Rectum, vol. 52, no. 3, pp. 526–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. C. Chang, P. C. Lin, S. H. Yang, H. S. Wang, W. Y. Liang, and J. K. Lin, “Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations,” International Journal of Colorectal Disease, vol. 24, no. 6, pp. 623–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Lièvre, C. Chapusot, A.-M. Bouvier et al., “Clinical value of mitochondrial mutations in colorectal cancer,” Journal of Clinical Oncology, vol. 23, no. 15, pp. 3517–3525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. L. F. de Araujo, A. S. Fonseca, B. R. Muys et al., “Mitochondrial genome instability in colorectal adenoma and adenocarcinoma,” Tumor Biology, vol. 36, no. 11, pp. 8869–8879, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Cui, P. Huang, Z. Wang et al., “Association of decreased mitochondrial DNA content with the progression of colorectal cancer,” BMC Cancer, vol. 13, article 110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Feng, L. Xiong, Z. Ji, W. Cheng, and H. Yang, “Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer,” Oncology Letters, vol. 2, no. 5, pp. 899–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. W. Lim, H. R. Kim, H. Y. Kim et al., “High-frequency minisatellite instability of the mitochondrial genome in colorectal cancer tissue associated with clinicopathological values,” International Journal of Cancer, vol. 131, no. 6, pp. 1332–1341, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. H.-C. Lee, P.-H. Yin, J.-C. Lin et al., “Mitochondrial genome instability and mtDNA depletion in human cancers,” Annals of the New York Academy of Sciences, vol. 1042, pp. 109–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. W. R. R. Geurts-Giele, G. H. G. K. Gathier, P. N. Atmodimedjo, H. J. Dubbink, and W. N. M. Dinjens, “Mitochondrial D310 mutation as clonal marker for solid tumors,” Virchows Archiv, vol. 467, no. 5, pp. 595–602, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Wang, S. Zhao, Y. Du, and Z. Guo, “Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with colorectal cancer outcome,” Mitochondrial DNA Part A: DNA Mapping, Sequencing, and Analysis, vol. 27, no. 6, pp. 4361–4363, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Errichiello, A. Balsamo, M. Cerni, and T. Venesio, “Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis,” Journal of Molecular Medicine, vol. 93, no. 11, pp. 1271–1281, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Hibi, H. Nakayama, T. Yamazaki et al., “Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients,” International Journal of Cancer, vol. 94, no. 3, pp. 429–431, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. Gatalica, S. Vranic, J. Xiu, J. Swensen, and S. Reddy, “High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine,” Familial Cancer, vol. 15, no. 3, pp. 405–412, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Venderbosch, S. van Vliet, M. H. C. Craenmehr et al., “Mitochondrial microsatellite instability in patients with metastatic colorectal cancer,” Virchows Archiv, vol. 466, no. 5, pp. 495–502, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Linkowska, A. Jawien, A. Marszałek, K. Skonieczna, and T. Grzybowski, “Searching for association of the CAG repeat polymorphism in the mitochondrial DNA polymerase gamma gene (POLG) with colorectal cancer,” Acta Biochimica Polonica, vol. 62, no. 3, pp. 625–627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Mohammed, A. R. Rezaee khorasany, E. Mosaieby, and M. Houshmand, “Mitochondrial A12308G alteration in tRNA(Leu(CUN)) in colorectal cancer samples,” Diagnostic Pathology, vol. 10, no. 1, article 115, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Miwata, T. Hiyama, D. T. R. Quach et al., “Differences in K-ras and mitochondrial DNA mutations and microsatellite instability between colorectal cancers of Vietnamese and Japanese patients,” BMC Gastroenterology, vol. 14, article 203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Dimberg, T. T. Hong, M. Skarstedt, S. Löfgren, N. Zar, and A. Matussek, “Novel and differential accumulation of mitochondrial DNA deletions in Swedish and Vietnamese patients with colorectal cancer,” Anticancer Research, vol. 34, no. 1, pp. 147–152, 2014. View at Google Scholar · View at Scopus
  56. N. G. Ericson, M. Kulawiec, M. Vermulst et al., “Decreased mitochondrial DNA mutagenesis in human colorectal cancer,” PLoS Genetics, vol. 8, no. 6, Article ID e1002689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. T. C. Larman, S. R. DePalma, A. G. Hadjipanayis et al., “Spectrum of somatic mitochondrial mutations in five cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 14087–14091, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. C.-Y. Wang, H. Li, X.-D. Hao et al., “Uncovering the profile of somatic mtDNA mutations in Chinese Colorectal cancer patients,” PLoS ONE, vol. 6, no. 6, Article ID e21613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Shimomura, T. Hiyama, S. Oka et al., “Frequent somatic mutations of mitochondrial DNA in traditional serrated adenomas but not in sessile serrated adenomas of the colorectum,” Journal of Gastroenterology and Hepatology, vol. 26, no. 10, pp. 1565–1569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Akouchekian, M. Houshmand, M. H. H. Akbari, B. Kamalidehghand, and M. Dehghane, “Analysis of mitochondrial ND1 gene in human colorectal cancer,” Journal of Research in Medical Sciences, vol. 16, no. 1, pp. 50–55, 2011. View at Google Scholar · View at Scopus
  61. Y. Yusnita, M. D. Norsiah, and A. J. A Rahman, “Mutations in mitochondrial NADH dehydrogenase subunit 1 (mtND1) gene in colorectal carcinoma,” Malaysian Journal of Pathology, vol. 32, no. 2, pp. 103–110, 2010. View at Google Scholar · View at Scopus
  62. T. Chen, J. He, L. Shen et al., “The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer,” BMC Medical Genetics, vol. 12, article 8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Pinheiro, I. Veiga, C. Pinto et al., “Mitochondrial genome alterations in rectal and sigmoid carcinomas,” Cancer Letters, vol. 280, no. 1, pp. 38–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Webb, P. Broderick, I. Chandler et al., “Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk,” British Journal of Cancer, vol. 99, no. 12, pp. 2088–2093, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J.-H. Lee, I. Hwang, Y.-N. Kang, I.-J. Choi, and D.-K. Kim, “Genetic characteristics of mitochondrial DNA was associated with colorectal carcinogenesis and its prognosis,” PLoS ONE, vol. 10, no. 3, Article ID e0118612, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. H. S. Kim, H. S. Lim, S. H. Lee et al., “Mitochondrial microsatellite instability of colorectal cancer stroma,” International Journal of Cancer, vol. 119, no. 11, pp. 2607–2611, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Govatati, S. Malempati, B. Saradamma et al., “Manganese-superoxide dismutase (Mn-SOD) overexpression is a common event in colorectal cancers with mitochondrial microsatellite instability,” Tumor Biology, vol. 37, no. 8, pp. 10357–10364, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Takeuchi, A. Fujimoto, and D. S. B. Hoon, “Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients,” Annals of the New York Academy of Sciences, vol. 1022, pp. 50–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Adams Jr., S. Mehrabi, Y. Vatcharapijarn et al., “Frequencies of mtDNA mutations in primary tissues of colorectal adenopolyps,” Frontiers in Bioscience (Elite Edition), vol. 5, no. 3, pp. 809–813, 2013. View at Google Scholar · View at Scopus
  70. N. Chihara, T. Amo, A. Tokunaga et al., “Mitochondrial DNA alterations in colorectal cancer cell lines,” Journal of Nippon Medical School, vol. 78, no. 1, pp. 13–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Ashktorab, S. Ahuja, L. Kannan et al., “A meta-analysis of MSI frequency and race in colorectal cancer,” Oncotarget, vol. 7, no. 23, pp. 34546–34557, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Srdjan, A. Jadranka, D. Ivan et al., “Microsatellite instability & survival in patients with stage II/III colorectal carcinoma,” The Indian Journal of Medical Research, vol. 143, pp. S104–S111, 2016. View at Publisher · View at Google Scholar
  73. E. N. Mojarad, S. M. H. Kashfi, H. Mirtalebi et al., “Low level of microsatellite instability correlates with poor clinical prognosis in stage II colorectal cancer patients,” Journal of Oncology, vol. 2016, Article ID 2196703, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  74. G. Guleng, T. Løvig, G. I. Meling, S. N. Andersen, and T. O. Rognum, “Mitochondrial microsatellite instability in colorectal carcinomas—frequency and association with nuclear microsatellite instability,” Cancer Letters, vol. 219, no. 1, pp. 97–103, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. F. M. da Cunha, N. Q. Torelli, and A. J. Kowaltowski, “Mitochondrial retrograde signaling: triggers, pathways, and outcomes,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 482582, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Srinivasan, M. Guha, A. Kashina, and N. G. Avadhani, “Mitochondrial dysfunction and mitochondrial dynamics—the cancer connection,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, 2017. View at Publisher · View at Google Scholar
  77. M. Miyo, M. Konno, H. Colvin et al., “The importance of mitochondrial folate enzymes in human colorectal cancer,” Oncology Reports, vol. 37, no. 1, pp. 417–425, 2017. View at Publisher · View at Google Scholar
  78. L. Formentini, M. Sánchez-Aragó, L. Sánchez-Cenizo, and J. M. C. Cuezva, “The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response,” Molecular Cell, vol. 45, no. 6, pp. 731–742, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. C. C. Hsu, L. M. Tseng, and H. C. Lee, “Role of mitochondrial dysfunction in cancer progression,” Experimental Biology and Medicine, vol. 241, no. 12, pp. 1281–1295, 2016. View at Publisher · View at Google Scholar · View at Scopus